While IDH-mutant astrocytomas have a poorer prognosis than IDH-mutant, 1p/19q codeleted oligodendrogliomas, IDH-mutant glioblastomas have a considerably better prognosis than IDH-wildtype glioblastomas [59]. The gene discussed is IDH2; the disease is oligodendroglioma.